Genetic Signatures

Cover Page	1
Our Vision & Purpose	2
Chairman’s Letter	4
EasyScreen detection kits	5
CEO Report	6
Genetic Signatures	7
Full Year Results Highlights	8
FY21 financial highlights	9
Asia Pacific	10
North America	11
EMEA Europe	12
Expanding Range of EasyScreen	14
Dermatophytes	15
Our people	16
Staff allocation by function	17
SARS-CoV-2 Update	18
Identifying and Mapping Strains	19
Contents	20
Financial Report 2021	21
Directors’ Report	22
Gross margins on materials	23
Directors’ Report	24
Directors	25
Directors’ Report	26
For the financial year ended	27
Directors’ Report	28
Remuneration Report	30
For the financial year ended	31
Remuneration Report	32
For the financial year ended	33
Remuneration Report	34
For the financial year ended	35
Financial Report	36
Consolidated Statement	37
Financial Report	38
Consolidated Statement	39
Financial Report	40
Notes to the Financial Statements	41
Financial Report	42
Notes to the Financial Statements	43
Financial Report	44
Notes to the Financial Statements	45
Financial Report	46
Notes to the Financial Statements	47
Financial Report	48
Notes to the Financial Statements	49
Financial Report	50
Notes to the Financial Statements	51
Financial Report	52
Notes to the Financial Statements	53
Financial Report	54
Notes to the Financial Statements	55
Financial Report	56
Notes to the Financial Statements	57
Financial Report	58
Notes to the Financial Statements	59
Financial Report	60
Notes to the Financial Statements	61
Financial Report	62
Notes to the Financial Statements	63
Directors’ Declaration	64
Auditor’s Declaration	65
Independent Auditor’s Report	66
BDO	67
Independent Auditor’s Report	68
BDO	69
Analysis of Holdings	70
Shareholder Information	71
Last Page	72

Made with FlippingBook

RkJQdWJsaXNoZXIy MTI3ODI1